Cooperative Agreement 2448823
Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Dallas, TX 75230, USA
Similar Awards
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) Project Grant award of $275,000 to Astria Biosciences, Inc. seeks to develop the first simple, whole blood-based diagnostic test to detect the presence and monitor the progression of cerebral aneurysms (CAs). The project aims to generate a robust dataset of CA patient blood samples, with a focus on increasing representation from underserved...
- This National Science Foundation (NSF) Cooperative Agreement award, under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $999,988 in funding to Dasion Corporation to develop a healthcare technology platform that utilizes geometric unified learning. The platform aims to enhance the efficiency and accuracy of healthcare diagnostics and monitoring, particularly for diseases that can be diagnosed and monitored using data sources like voice and EEG. The project...
- This Small Business Technology Transfer (STTR) Phase I project, funded by the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop and validate a virtual reality (VR)-based platform that integrates cognitive assessment and enhancement through perceptual training. The $305,000 award, granted on Mar 1, 2025, with a completion date of Nov 30, 2025, will enable Elite Neuro Inc. to create an immersive VR solution that addresses...
- This $1,199,991 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program aims to develop novel technologies for real-time assessment of blood clot properties to improve stroke treatment. The key products and services under this grant include: Integration of a sub-millimeter Raman fiber probe into a catheter for intravascular, in-vivo measurement of clot chemical composition. Training of a convolutional neural network to...
- This $983,137 Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a biofeedback system for adults with Parkinson's disease who have speech disorders. The project aims to create a product that can detect and report on communicative disorders in adults, allowing them to better communicate and live productive lives, while also reducing the overall burden on the...
- This $997,693 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an interactive health assessment and monitoring platform to improve patient-provider communication and reduce healthcare costs. The project by Literaseed, Inc. integrates electronic health record (EHR) data with natural language processing (NLP) techniques to extract valuable information from medical records, enabling...
- Qas.ai Inc. was awarded a $255,577 Small Business Technology Transfer (STTR) Phase I Project Grant by the National Science Foundation on July 15, 2021 to develop an AI-enhanced angiographic system to guide endovascular treatment of intracranial aneurysms. The STTR Phase I Project Grant program, administered under the National Science Foundation's Technology, Innovation, and Partnerships Directorate (TIP), provides funding for the exploration of the technical feasibility or scientific merit of an...
- This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $959,066 in funding to Jelikalite Corp. to develop a non-invasive therapeutic brain stimulation medical device to improve communication, responsiveness, and social integration for autistic children. The project aims to finalize a prototype device that delivers transcranial photobiomodulation (TPBM) therapy based on integrated...
- This National Science Foundation (NSF) Cooperative Agreement award, under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $999,553 to Dynocardia, Inc. to develop advanced computer vision and artificial intelligence algorithms for motion artifact correction in their Vitrack wearable blood pressure monitoring device. The project aims to improve the accuracy and reliability of Vitrack's continuous, non-invasive blood pressure measurements in clinical settings, where...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $299,982 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Unandup, LLC, a technology development firm in St. Louis, Missouri. The grant funding supports the development of the Commercialization Readiness Pilot for the FAST (Flow Acceleration for Stroke Thrombolysis) System, an innovative medical device platform designed to safely accelerate the...